← Back to Search

Other

Platelet Rich Plasma Tear Drops for Dry Eye Syndrome

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 months
Awards & highlights

Study Summary

This trial will test whether using plasma tears can improve dry eye symptoms in patients. There will be two groups who will either receive plasma tears with platelets or without.

Eligible Conditions
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean change in acuity
Mean change in breakup pattern to appear
Mean change in consistency of lipid compensation
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Platelet Rich Plasma TearsExperimental Treatment1 Intervention
Group II: Platelet Poor Plasma TearActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
838 Previous Clinical Trials
518,552 Total Patients Enrolled

Media Library

Platelet Poor Plasma Tear Drops (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05121493 — N/A
Dry Eye Syndrome Research Study Groups: Platelet Poor Plasma Tear, Platelet Rich Plasma Tears
Dry Eye Syndrome Clinical Trial 2023: Platelet Poor Plasma Tear Drops Highlights & Side Effects. Trial Name: NCT05121493 — N/A
Platelet Poor Plasma Tear Drops (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05121493 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment welcome elderly participants?

"The age entrance parameters for this clinical trial stipulate that participants must be 18 years old or older, but not exceed 75."

Answered by AI

Are any slots available for patient participation in this research endeavor?

"The clinical trial in question is no longer accepting new patients; the post was initially published on July 1st 2022 and its last update occurred a week later. As of now, there are 76 other studies recruiting participants across the nation."

Answered by AI

Do I meet the qualifications to join this clinical trial?

"15 volunteers aged between 18-75 with clinically significant dry eye are sought for this medical trial. To qualify, the individual must meet a range of criteria such as no active ocular disease or allergic conjunctivitis, being willing to comply with instructions and meeting plasma donor standards set by University of Rochester Transfusion Medicine & Blood Bank. Additionally they should not have been using topical ocular medications within two weeks prior to enrolment."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
South Carolina
What site did they apply to?
Flaum Eye Institute at the University of Rochester
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
Recent research and studies
clinicaltrials.govStudy
Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye
James V. Aquavella, MD 2023. "Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05121493.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top